6622 — Zhaoke Ophthalmology Cashflow Statement
0.000.00%
- HK$939.36m
- -HK$74.71m
- CNY69.32m
Annual cashflow statement for Zhaoke Ophthalmology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -727 | -2,130 | -407 | -384 | -237 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 623 | 1,856 | 40.5 | -46.7 | -28.1 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -19 | 2.91 | 0.646 | 58.8 | -41.7 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -103 | -245 | -331 | -324 | -254 |
Capital Expenditures | -135 | -79.4 | -239 | -95.3 | -44.1 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -821 | 763 | -86 | 19.5 | -72.4 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -955 | 684 | -325 | -75.8 | -116 |
Financing Cash Flow Items | -3.03 | -81 | -3.14 | -5.88 | -9.78 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 974 | 1,659 | 76.2 | 99.3 | -12.1 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -89.7 | 2,063 | -412 | -255 | -341 |